{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:08:09Z","timestamp":1781712489648,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T00:00:00Z","timestamp":1736294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Distinguished Taishan Scholars in Climbing Plan","award":["tspd20210321"],"award-info":[{"award-number":["tspd20210321"]}]},{"name":"the Distinguished Taishan Scholars Plan","award":["tstp20230653"],"award-info":[{"award-number":["tstp20230653"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270174, 82170182, 82070160"],"award-info":[{"award-number":["82270174, 82170182, 82070160"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00277-025-06183-7","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T03:45:04Z","timestamp":1736307904000},"page":"1039-1046","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["PEG-rhG-CSF versus rhG-CSF in supporting neutrophil recovery after induction chemotherapy for patients with newly diagnosed acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"104","author":[{"given":"Shumin","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruinan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W\u011bi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingtao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,8]]},"reference":[{"issue":"11","key":"6183_CR1","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.4065\/80.11.1517","volume":"80","author":"EJ Jabbour","year":"2005","unstructured":"Jabbour EJ, Faderl S, Kantarjian HM (2005) Adult Acute Lymphoblastic Leukemia. Mayo Clin Proc 80(11):1517\u20131527. https:\/\/doi.org\/10.4065\/80.11.1517","journal-title":"Mayo Clin Proc"},{"key":"6183_CR2","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMra023001","volume":"350","author":"MD Ching-Hon Pui","year":"2004","unstructured":"Ching-Hon Pui MD, Mary V, Relling PD, James R, Downing MD (2004) Acute lymphoblastic leukemia. N Engl J Med 350:1535\u20131548. https:\/\/doi.org\/10.1056\/NEJMra023001","journal-title":"N Engl J Med"},{"key":"6183_CR3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMra0803109","volume":"359","author":"MD Stefan Fr\u00f6hling","year":"2008","unstructured":"Stefan Fr\u00f6hling MD, Hartmut D\u00f6hner MD (2008) Chromosomal abnormalities in Cancer. N Engl J Med 359:722\u2013734. https:\/\/doi.org\/10.1056\/NEJMra0803109","journal-title":"N Engl J Med"},{"issue":"2","key":"6183_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.critrevonc.2004.04.008","volume":"56","author":"T Haferlach","year":"2005","unstructured":"Haferlach T, Kern W, Schnittger S, Schoch C (2005) Modern diagnostics in acute leukemias. Crit Rev Oncol\/Hematol 56(2):223\u2013234. https:\/\/doi.org\/10.1016\/j.critrevonc.2004.04.008","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"9","key":"6183_CR5","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3760\/cma.j.issn.0253-2727.2021.09.001","volume":"42","author":"Q Lugui","year":"2021","unstructured":"Hematology Oncology Committee CA-CA, Leukemia & Lymphoma Group CSoH, Chinese Medical Association, Lugui Q, Jianxiang W (2021) Chinese guidelines for diagnosis and treatment of adult acute lymphoblastic leukemia. Chin J Hematol 42(9):705\u2013716. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2021.09.001","journal-title":"Chin J Hematol"},{"key":"6183_CR6","doi-asserted-by":"publisher","unstructured":"Fran\u00e7oise Huguet S, Chevret T, Leguay X, Thomas N, Boissel M, Escoffre-Barbe P, Chevallier MH, Norbert Vey C, Bonmati ED, Macintyre E, Chalandon Y (2018) Norbert Ifrah, Herv\u00b4 e Dombret ftGo, (GRAALL) RoAA intensified iherapy of acute lymphoblastic leukemia in adults: report of the randomized GRAALL-2005 clinical trial. J Clin Oncol 36(24):2514\u20132523. https:\/\/doi.org\/10.1200\/JCO.2017.76.8192","DOI":"10.1200\/JCO.2017.76.8192"},{"issue":"5","key":"6183_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3969\/j.issn.1009-2137.2007.05.042","volume":"15","author":"Z Wei","year":"2007","unstructured":"Wei Z, Rong F, Wenhui L, Yuqian C, Wenxiu S, Lijuan D, Erbao R, Litong; Z, Xiaoming; W, Yong L (2007) Analysis of prognosis and related factors in acute lymphoblastic leukemia. Chin J Experimental Hematol 15(5):5. https:\/\/doi.org\/10.3969\/j.issn.1009-2137.2007.05.042","journal-title":"Chin J Experimental Hematol"},{"key":"6183_CR8","doi-asserted-by":"publisher","unstructured":"Michel G, Landman-Parker J, Auclerc MF, Mathey C, Leblanc T, Legall E, Bordigoni P, Lamagnere JP, Demeocq F, Perel Y, Auvrignon A, Berthou C, Bauduer F, Pautard B, Schneider P, Schaison G, Leverger G, Baruchel A (2000) Use of recombinant human granulocyte colony stimulating factor to increase chemotherapy Dose-Intensity: a randomized trial in very high-risk childhood Acute Lymphoblastic Leukemia. J Clin Oncol 1517\u20131524. https:\/\/doi.org\/10.1200\/JCO.2000.18.7.1517","DOI":"10.1200\/JCO.2000.18.7.1517"},{"issue":"2","key":"6183_CR9","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1182\/blood.V86.2.444.bloodjournal862444","volume":"86","author":"OG Ottmann","year":"1995","unstructured":"Ottmann OG, Hoelzer D, Gracien E, Ganser A, Kelly K, Reutzel R, Lipp T, Busch FW, Schwonzen M, Heil G (1995) Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial. Blood 86(2):444\u2013450. https:\/\/doi.org\/10.1182\/blood.V86.2.444.bloodjournal862444","journal-title":"Blood"},{"issue":"4","key":"6183_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ajh.1052","volume":"66","author":"E van der Phillippe","year":"2001","unstructured":"van der Phillippe E, Platzer Z-X, Xu R, Schulz O, Feugeas R, Capdeville, Edwards DJ (2001) Pharmacodynamics and pharmacokinetics of single doses of Subcutaneous Pegylated Human G-CSF Mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of Filgrastim. Am J Hematol 66(4):245\u2013251. https:\/\/doi.org\/10.1002\/ajh.1052","journal-title":"Am J Hematol"},{"issue":"16","key":"6183_CR11","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3760\/cma.j.issn.0376-2491.2018.16.009","volume":"98","author":"J Zefei","year":"2018","unstructured":"Zefei J, Fengrui X, Jing F, Baojiang L, Jinnan G, Jiwei H, Xiaojia W, Yongqiang Z, Jianhong W, Fei L, Qiang L, Yinhua L, Shu W, Yongsheng W, Quchang O, Bing H, Guoping S, Yan Z, Aimin Z, Peizhi F, Changping W, Jian L, Hongwei Z, Wei W, Xichun H, Lili T, Jing Z, Yangyi B, Cuizhi G, Qiang S, Feng Z, Yongmei Y, Hongchuan J, Yonghui A (2018) A multicenter, randomized, controlled, phase IV clinical study of PEG-rhG-CSF for preventing chemotherapy induced neutropenia in patients with breast cancer. Chin J Hematol 98(16):1231\u20131235. https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2018.16.009","journal-title":"Chin J Hematol"},{"issue":"17","key":"6183_CR12","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1111\/1759-7714.14544","volume":"13","author":"XS Sun","year":"2022","unstructured":"Sun XS, Wang Z, Ren SH, Zhang HL, Liu LJ, Du HB, Liu XW, Liu JF (2022) PEG-rhG\u2010CSF for prophylaxis of neutropenia after chemotherapy in patients with non\u2013small cell lung cancer: a multicenter, prospective, randomized study. Thorac Cancer 13(17):2429\u20132435. https:\/\/doi.org\/10.1111\/1759-7714.14544","journal-title":"Thorac Cancer"},{"issue":"13","key":"6183_CR13","doi-asserted-by":"publisher","first-page":"14130","DOI":"10.1002\/cam4.6079","volume":"12","author":"J Huang","year":"2023","unstructured":"Huang J, Lu S, Wang J, Jiang L, Luo X, He X, Wu Y, Wang Y, Zhu X, Chen J, Tang Y, Chen K, Tian X, Shi B, Guo L, Zhu J, Sun F, Zhen Z, Zhang Y (2023) A multicenter phase II trial of primary prophylactic PEG-rhG\u2010CSF in pediatric patients with solid tumors and non\u2010Hodgkin lymphoma after chemotherapy: an interim analysis. Cancer Med 12(13):14130\u201314137. https:\/\/doi.org\/10.1002\/cam4.6079","journal-title":"Cancer Med"},{"key":"6183_CR14","doi-asserted-by":"publisher","unstructured":"Howard A, Burris III, Chandra P, Belani, Peter A, Kaufman, Alan N, Gordon LS, Schwartzberg WS, Paroly S, Shahin L, Dreiling, Alan Saven (2010) PegfilgrastimontheSameDayVersusNextDay of ChemotherapyinPatientsWithBreastCancer,non\u2013Small-cell LungCancer,OvarianCancer,andNon-Hodgkin\u2019sLymphoma: ResultsofFourMulticenter,Double-Blind,RandomizedPhase IIStudies. JCO Oncol Pract 6(3):133\u2013140. https:\/\/doi.org\/10.1200\/JOP.091094","DOI":"10.1200\/JOP.091094"},{"issue":"3","key":"6183_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1200\/JOP.2011.000360","volume":"8","author":"M Chris","year":"2012","unstructured":"Chris M, Kozma M, Dickson V, Chia J, Legg, Barron R (2012) Trends in Neutropenia-related inpatient events. JCO Oncol Pract 8(3):149\u2013155. https:\/\/doi.org\/10.1200\/JOP.2011.000360","journal-title":"JCO Oncol Pract"},{"issue":"14","key":"6183_CR16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3969\/j.issn.1000-8179.2017.14.291","volume":"44","author":"XJ SHI Yuankai","year":"2017","unstructured":"SHI Yuankai XJ, Changping WU, Yan ZHANG, Junquan YANG, Tao ZHOU, Zheng LIU, Weidong MAO, Yiping ZHANG, Wei WANG, Zhonghe YU, Lin WU, Jianhua CHEN, Juan WANG, Yonghui AN, Jianhui CAI, Ming LIU, Zhendong CHEN, Qingshan LI, Chaoying REN, Zhiyong YANG, Baolan LI, Min ZHAO, Zhefeng LIU, LIU Bin (2017) Multicenter postmarketing clinical study on using pegylated recombinant human granulocyte-colony stimulating factor to prevent chemotherapy-induced neutropenia. Chin J Clin Oncol 44(14):679\u2013684. https:\/\/doi.org\/10.3969\/j.issn.1000-8179.2017.14.291","journal-title":"Chin J Clin Oncol"},{"issue":"23","key":"6183_CR17","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.1200\/JCO.2008.21.0856","volume":"27","author":"RD Portugal","year":"2009","unstructured":"Portugal RD, Garnica M, Nucci M (2009) Index to predict invasive mold infection in high-risk neutropenic patients based on the Area over the Neutrophil curve. J Clin Oncol 27(23):3849\u20133854. https:\/\/doi.org\/10.1200\/JCO.2008.21.0856","journal-title":"J Clin Oncol"},{"issue":"4","key":"6183_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1159\/000522037","volume":"145","author":"SI Kimura","year":"2022","unstructured":"Kimura SI, Nakamura Y, Kawamura M, Takeshita J, Kawamura S, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Okada Y, Akahoshi Y, Tamaki M, Kusuda M, Kameda K, Wada H, Sato M, Tanihara A, Nakasone H, Kako S, Kanda Y (2022) Neutropenia in the First cycle of consolidation chemotherapy with high-dose cytarabine is not Associated with the incidence of Relapse in Adult Acute myeloid leukemia patients in First Complete Remission. Acta Haematol 145(4):404\u2013411. https:\/\/doi.org\/10.1159\/000522037","journal-title":"Acta Haematol"},{"key":"6183_CR19","doi-asserted-by":"publisher","unstructured":"Sierra J, Szer J, Kassis J, Herrmann R, Lazzarino M, Thomas X, Noga SJ, Baker N, Dansey R, Bosi A (2008) A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial. BMC Cancer 8(1). https:\/\/doi.org\/10.1186\/1471-2407-8-195","DOI":"10.1186\/1471-2407-8-195"},{"key":"6183_CR20","doi-asserted-by":"publisher","unstructured":"Ma H, Sun H, Sun X (2014) Survival improvement by decade of patients aged 0\u201314 years with acute lymphoblastic leukemia: a SEER analysis. Sci Rep 4(1). https:\/\/doi.org\/10.1038\/srep04227","DOI":"10.1038\/srep04227"},{"key":"6183_CR21","doi-asserted-by":"publisher","unstructured":"DeAngelo DJ, Jabbour E, Advani A (2020) Recent advances in managing Acute Lymphoblastic Leukemia. American Society of Clinical Oncology Educational Book. 40:330\u2013342. https:\/\/doi.org\/10.1200\/edbk_280175","DOI":"10.1200\/edbk_280175"},{"issue":"10230","key":"6183_CR22","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","volume":"395","author":"M Florent Malard, Mohty","year":"2020","unstructured":"Florent Malard, Mohty M (2020) Acute lymphoblastic leukaemia. Lancet J 395(10230):1146\u20131162. https:\/\/doi.org\/10.1016\/S0140-6736(19)33018-1","journal-title":"Lancet J"},{"issue":"11","key":"6183_CR23","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.1007\/s00520-020-05603-w","volume":"28","author":"X Li","year":"2020","unstructured":"Li X, Zheng H, Yu M-C, Wang W, Wu X-H, Yang D-M, Xu J (2020) Is PEGylated G-CSF superior to G-CSF in patients with breast cancer receiving chemotherapy? A systematic review and meta-analysis. Support Care Cancer 28(11):5085\u20135097. https:\/\/doi.org\/10.1007\/s00520-020-05603-w","journal-title":"Support Care Cancer"},{"key":"6183_CR24","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2020.11017","author":"L Liu","year":"2020","unstructured":"Liu L, Liu Y, Yan X, Zhou C, Xiong X (2020) The role of granulocyte colony\u2013stimulating factor in breast cancer development: a review. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2020.11017","journal-title":"Mol Med Rep"},{"issue":"14","key":"6183_CR25","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3969\/j.issn.1000-8179.2019.14.967","volume":"46","author":"F Li Huiping","year":"2019","unstructured":"Li Huiping F, Zhengfu Z, Yunong HG, Meifeng T, Guohong S, Bing S, Tian G, Jun Z (2019) Efficacy and safety of PEG-rhG-CSF therapy in the primary and secondary prevention of chemotherapy-induced neutropenia. Chin J Clin Oncol 46(14):739\u2013744. https:\/\/doi.org\/10.3969\/j.issn.1000-8179.2019.14.967","journal-title":"Chin J Clin Oncol"},{"issue":"6","key":"6183_CR26","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/jca.21550","volume":"32","author":"JW Kuan","year":"2017","unstructured":"Kuan JW, Su AT, Leong CF (2017) Pegylated granulocyte-colony stimulating factor versus non\u2010pegylated granulocyte\u2010colony stimulating factor for peripheral blood stem cell mobilization: a systematic review and meta\u2010analysis. J Clin Apheresis 32(6):517\u2013542. https:\/\/doi.org\/10.1002\/jca.21550","journal-title":"J Clin Apheresis"},{"key":"6183_CR27","doi-asserted-by":"publisher","unstructured":"Jiang Y, Zhang J, Zhong J, Liao H, Zhang J, Liu Y, Liang Y, Li H (2023) Efficacy and safety of PEG-rhG-CSF versus rhG-CSF in preventing chemotherapy-induced-neutropenia in early-stage breast cancer patients. BMC Cancer 23(1). https:\/\/doi.org\/10.1186\/s12885-023-11198-2","DOI":"10.1186\/s12885-023-11198-2"},{"issue":"2","key":"6183_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3816\/CCC.2010.n.013","volume":"9","author":"JR Hecht","year":"2010","unstructured":"Hecht JR, Pillai M, Gollard R, Heim W, Swan F, Patel R, Dreiling L, Mo M, Malik I (2010) A Randomized, Placebo-Controlled phase II study evaluating the reduction of Neutropenia and Febrile Neutropenia in patients with Colorectal Cancer receiving Pegfilgrastim with every-2-Week chemotherapy. Clin Colorectal Cancer 9(2):95\u2013101. https:\/\/doi.org\/10.3816\/CCC.2010.n.013","journal-title":"Clin Colorectal Cancer"},{"issue":"6","key":"6183_CR29","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/JTO.0b013e318060107c","volume":"2","author":"F Richard","year":"2007","unstructured":"Richard F, Riedel C, Andrews J, Garst F, Dunphy JE, Herndon II, Blackwell S, Barbour S, Crawford J (2007) A phase II trial of carboplatin\/vinorelbine with pegfilgrastim support for the treatment of patients with advanced non-small cell lung cancer. J Thorac Oncol 2(6):520\u2013525. https:\/\/doi.org\/10.1097\/JTO.0b013e318060107c","journal-title":"J Thorac Oncol"},{"issue":"2","key":"6183_CR30","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1200\/JCO.1996.14.2.636","volume":"14","author":"JY Blay FC","year":"1996","unstructured":"Blay FC JY, Cesne AL, Anglaret B, Bouhour D, Lasset C, Freyer G, Philip T, BironAUTHORS P, AFFILIATIONS (1996) Early Lymphopenia after cytotoxic chemotherapy as a risk factor for Febrile Neutropenia. J Clin Oncol 14(2):636\u2013643","journal-title":"J Clin Oncol"},{"issue":"2","key":"6183_CR31","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00520-014-2457-z","volume":"23","author":"AM Pfeil","year":"2014","unstructured":"Pfeil AM, Allcott K, Pettengell R, von Minckwitz G, Schwenkglenks M, Szabo Z (2014) Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review. Support Care Cancer 23(2):525\u2013545. https:\/\/doi.org\/10.1007\/s00520-014-2457-z","journal-title":"Support Care Cancer"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06183-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06183-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06183-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T18:31:19Z","timestamp":1743877879000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06183-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["6183"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06183-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,8]]},"assertion":[{"value":"29 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The retrospective, observational study was approved by the Ethics Committee of Qilu Hospital, Shandong University, and was conducted in accordance with the Declaration of Helsinki. All authors of this article agree to publish in your journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The Ethics Committee of Qilu Hospital approved waiving the need to obtain written informed consent from each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}